SGMT earnings date and last-quarter result: next report 2026-08-12, last quarter beat, P/E -5.22. Updated 2026-07-23.
Sagimet Biosciences (SGMT) Research Hub
Sagimet Biosciences (SGMT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 9.56 USD (-0.21%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -5.22, market cap 0.23B. This hub links to the full technical, earnings and options research available for SGMT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 9.56 USD (-0.21%) |
| 52-week range | 6.31 USD – 11.45 USD |
| Trend regime | Range |
| 14-day RSI | 58.5 (Bullish) |
| Trailing P/E | -5.22 |
| Market cap | 0.23B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for SGMT
Covered Call on SGMT: how it works, illustrative setup around the real 9.56 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SGMT: how it works, illustrative setup around the real 9.56 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SGMT: how it works, illustrative setup around the real 9.56 USD price, max profit/loss, breakeven and when to use it. Educational.
SGMT technical analysis: range, last 9.56 USD, RSI 58.5, 52w range 6.31 USD–11.45 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SGMT in?
Sagimet Biosciences (SGMT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is SGMT in an uptrend or downtrend?
As of 2026-10-26, SGMT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SGMT's trailing P/E ratio?
SGMT's trailing P/E is -5.22, with a market cap of 0.23B. See the earnings research page for full valuation detail.
When does SGMT next report earnings?
SGMT is next scheduled to report earnings on 2026-08-12.